WO1998040404A3 - Secreted proteins and polynucleotides encoding them - Google Patents

Secreted proteins and polynucleotides encoding them Download PDF

Info

Publication number
WO1998040404A3
WO1998040404A3 PCT/US1998/004601 US9804601W WO9840404A3 WO 1998040404 A3 WO1998040404 A3 WO 1998040404A3 US 9804601 W US9804601 W US 9804601W WO 9840404 A3 WO9840404 A3 WO 9840404A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides encoding
secreted proteins
proteins
secreted
polynucleotides
Prior art date
Application number
PCT/US1998/004601
Other languages
French (fr)
Other versions
WO1998040404A2 (en
Inventor
Kenneth Jacobs
John M Mccoy
Edward R Lavallie
Lisa A Racie
David Merberg
Maurice Treacy
Vikki Spaulding
Michael J Agostino
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Priority to EP98911532A priority Critical patent/EP0970109A2/en
Priority to AU65468/98A priority patent/AU6546898A/en
Priority to CA002283193A priority patent/CA2283193A1/en
Priority to JP53968398A priority patent/JP2001514520A/en
Publication of WO1998040404A2 publication Critical patent/WO1998040404A2/en
Publication of WO1998040404A3 publication Critical patent/WO1998040404A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Abstract

Novel polynucleotides and the proteins encoded thereby are disclosed.
PCT/US1998/004601 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them WO1998040404A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP98911532A EP0970109A2 (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them
AU65468/98A AU6546898A (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them
CA002283193A CA2283193A1 (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them
JP53968398A JP2001514520A (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81538197A 1997-03-11 1997-03-11
US3632198A 1998-03-06 1998-03-06
US08/815,381 1998-03-06
US09/036,321 1998-03-06

Publications (2)

Publication Number Publication Date
WO1998040404A2 WO1998040404A2 (en) 1998-09-17
WO1998040404A3 true WO1998040404A3 (en) 1998-12-30

Family

ID=26713058

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/004601 WO1998040404A2 (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them

Country Status (5)

Country Link
EP (1) EP0970109A2 (en)
JP (1) JP2001514520A (en)
AU (1) AU6546898A (en)
CA (1) CA2283193A1 (en)
WO (1) WO1998040404A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1144603A3 (en) * 1999-01-22 2002-02-06 Memorec Medical Molecular Research Cologne Stoffel GmbH Protease
AU5751000A (en) 1999-06-18 2001-01-09 Brook Biotechnologies, Inc. Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
CA2402310A1 (en) 2000-03-08 2001-09-13 Complexe Hospitalier De La Sagamie Very low density lipoprotein receptor polymorphisms and uses therefor
US20020132244A1 (en) 2000-09-27 2002-09-19 Xiao-Cheng Li-Sucholeiki Methods for detecting rare polymorphic variants in genomic DNA sequences
US9072766B2 (en) 2010-11-18 2015-07-07 Beth Israel Deaconess Medical Center, Inc. Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)
KR20210082212A (en) * 2018-10-25 2021-07-02 아지노모토 가부시키가이샤 secretory production method of protein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE NUCLEOTIDE PROTEIN SEQUENCE, - 15 March 1998 (1998-03-15), HINXTON, GB, XP002072089 *
DATABASE NUCLEOTIDE PROTEIN SEQUENCE, - 15 March 1998 (1998-03-15), XP002072090 *
DATABASE NUCLEOTIDE PROTEIN SEQUENCE, - 28 October 1997 (1997-10-28), HINXTON, GB, XP002072088 *
DATABASE NUCLEOTIDE PROTEIN SEQUENCE, - 6 February 1998 (1998-02-06), HINXTON, GB, XP002072072 *
Y. FUJIOKA ET AL.,: "A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion", MOLECULAR AND CELLULAR BIOLOGY, vol. 16, no. 12, 1996, WASHINGTON, DC, US, pages 6887 - 6899, XP002072087 *

Also Published As

Publication number Publication date
AU6546898A (en) 1998-09-29
EP0970109A2 (en) 2000-01-12
CA2283193A1 (en) 1998-09-17
WO1998040404A2 (en) 1998-09-17
JP2001514520A (en) 2001-09-11

Similar Documents

Publication Publication Date Title
WO1998007859A3 (en) Secreted proteins and polynucleotides encoding them
WO1998017687A3 (en) Secreted proteins and polynucleotides encoding them
WO1997007198A3 (en) Dna sequences and secreted proteins encoded thereby
WO1999057132A8 (en) Secreted proteins and polynucleotides encoding them
WO1998033916A3 (en) Secreted proteins and polynucleotides encoding them
WO1998042739A3 (en) Secreted proteins and polynucleotides encoding them
WO1998042741A3 (en) Secreted proteins and polynucleotides encoding them
WO1998004693A3 (en) Secreted proteins and polynucleotides encoding them
WO1998055614A3 (en) Secreted proteins and polynucleotides encoding them
WO2001075068A3 (en) Secreted proteins and polynucleotides encoding them
WO1998040486A3 (en) Secreted proteins and polynucleotides encoding them
WO1998005776A3 (en) Secreted proteins and polynucleotides encoding them
WO1998027205A3 (en) Secreted proteins and polynucleotides encoding them
WO1999058642A3 (en) Secreted proteins and polynucleotides encoding them
WO1998046757A3 (en) Secreted proteins and polynucleotides encoding them
WO1998037094A3 (en) Secreted proteins and polynucleotides encoding them
WO1998032853A3 (en) Secreted proteins and polynucleotides encoding them
AU6553898A (en) Human secreted protein, ba3.1, and polynucleotides encoding same
WO1998040404A3 (en) Secreted proteins and polynucleotides encoding them
WO1998056909A3 (en) Secreted proteins and polynucleotides encoding them
WO1998030589A3 (en) Secreted proteins and polynucleotides encoding them
WO1998041539A3 (en) Secreted proteins and polynucleotides encoding them
WO1998021332A3 (en) Secreted proteins and polynucleotides encoding them
WO1998031802A3 (en) Secreted proteins and polynucleotides encoding them
WO1998030696A8 (en) Secreted proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2283193

Country of ref document: CA

Ref country code: CA

Ref document number: 2283193

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 539683

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998911532

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998911532

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1998911532

Country of ref document: EP